FDA official quits over Plan B decision

Share this article:
The FDA's Office of Women's Health (OWH) director has resigned in protest over the agency's refusal to permit OTC sales of Barr's Plan B emergency contraceptive.
OWH director Susan Wood announced her resignation in an e-mail to agency colleagues.
The FDA declined to comment on Wood's departure.
The agency announced it would defer a decision on the politically sensitive drug, pending a 60-day public comment period. That decision came despite an earlier promise to Congress from FDA Commissioner Lester Crawford to make a final decision on Plan B by Sept. 1.
Senators Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) placed a hold on Crawford's nomination to commissioner in June, demanding a yes or no decision on the drug, but relented in July when he issued a Sept. 1 deadline.
"It is deeply disturbing that an agency long recognized for making decisions based on sound science has become so politicized that one of its most widely respected, long-serving veterans would feel disillusioned enough to quit in protest," Clinton and Murray said in a joint statement.
Share this article:

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.